Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EpCAM-SN-38 RNA Nanoparticle
- Development stage
- Preclinical
- Lead developer
- RNA NanoBiotics
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems, RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Intravenous
01
Overview
EpCAM-SN-38 RNA Nanoparticle is a preclinical therapeutic candidate developed by RNA NanoBiotics for the treatment of metastatic colorectal cancer (mCRC). The drug utilizes a programmable 4-way junction (4WJ) RNA nanoparticle architecture to deliver SN-38, the active metabolite of the topoisomerase I inhibitor irinotecan, specifically to cells expressing the Epithelial Cell Adhesion Molecule (EpCAM). By leveraging the stability and modularity of the 4WJ RNA scaffold, the nanoparticle is designed to enhance the delivery of the cytotoxic payload to tumor sites while minimizing systemic exposure and off-target toxicities associated with conventional chemotherapy.
- Other names
- EpCAM-targeted RNA nanoparticleRNA NanoBiotics EpCAM-SN-38
02
Targets
TOP1 (DNA Topoisomerase I)EPCAM (Epithelial cell adhesion molecule)
Beyond the preview
Go deeper on EpCAM-SN-38 RNA Nanoparticle.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EpCAM-SN-38 RNA Nanoparticle.